Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy

Cytotherapy

Volumn 5, Issue 2, 2003, Pages 147-152

  Padley, D J ^a   Greiner, C W ^a   Heddlesten Rediske, T L ^a   Hopkins, M K ^a   Maas, M L ^a   Gastineau, Dennis A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antigen presenting cells; Bacteriological techniques; Cellular vaccines; cGMP; Dendritic cells; Good manufacturing practices; Immunotherapy

Indexed keywords

ANTIBIOTIC AGENT; CANCER VACCINE;

ADULT; AGED; AMYLOIDOSIS; APHERESIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOOD CULTURE; CANCER; CANCER IMMUNOTHERAPY; CASE REPORT; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DONOR; FEMALE; GRAM POSITIVE COCCI; HISTOPLASMA CAPSULATUM; HUMAN; MALE; MICROBIAL CONTAMINATION; PROSTATE CANCER; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SPHINGOMONAS PAUCIMOBILIS; TISSUE CULTURE;

EID: 0038246385     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240310001046     Document Type: Article

References (19)

1. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; General. United States Code of Federal Regulations. 21 CFR 210. http://www.access.gpo.gov/nara/cfr/waisidx_02/21cfr210_02.html, visited 4 March 2003.
2. Current good manufacturing practice for finished pharmaceuticals. United States Code of Federal Regulations. 21 CFR 211. http://www.access.gpo.gov/nara/cfr/waisidx_02/21cfr211_02.html, visited 4 March 2003
3. Current good tissue practice for manufacturers of human cellular and tissue-based products. United States Code of Federal Regulations. 21 CFR 1271. http://www.access.gpo.gov/nara/cfr/waisidx_02/21cfr1271_02.html, visited 4 March 2003.
4. Alvarez FE, Rogge KJ, Tarrand J et al. Bacterial contamination of cellular blood components. A retrospective review at a large cancer center. Ann Clin Lab Sci 1995;25:283-90.
5. Engelfriet CP, Reesink HW, Blajchman MA et al. Bacterial contamination of blood components. Vox Sang 2000;78:59-67.
6. Blajchman MA, Ali AM, Richardson HL. Bacterial contamination of cellular blood components. Vox Sang 1994;67(Suppl. 3):25-33.
7. Padley D, Koontz F, Trigg ME et al. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996;36:53-6.
8. Schwella N, Zimmerman R, Heuft HG et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994;67:32-5.
9. Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991;5:73-83.
10. Rowley SD, Davis J, Dick J et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance. Transfusion 1988;28:109-12.
11. Morrow JF, Braine HG, Kickler TS et al. Septic reactions to platelet transfusions. A persistent problem. J Am Med Assoc 1991;266:555-8.
12. Burgstaler EA, Padley DJ, Pineda AA, et al. Use of Fenwal CS3000 Plus for collection of mononuclear cells for dendritic cell based immunotherapy (abstract). Transfusion 1998;38 Suppl:83S.
13. Murray PR, Baron EJ, Pfaller MA et al. (editors). Manual of Clinical Microbiology. Seventh Edition. Washington DC: ASM Press, 1999.
14. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, editors. Diagnostic Molecular Microbiology: Principles and Applications. First Edition. Washington DC: ASM Press, 1993: 563-72.
15. Attarian H, Bensinger WI, Buckner CD et al. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996;17:699-702.
16. Tipple MA, Bland LA, Murphy JJ et al. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion 1990;30:207-13.
17. Prince HM, Page SR, Keating A et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995;15:87-91.
18. Jestice HK, Farrington M, Hunt C et al. Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med 1996;6:103-10.
19. Webb IJ, Coral FS, Andersen JW et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: Implications for the safety of hematotherapy and graft engineering. Transfusion 1996;36:782-8.